secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2024-07-17T23:59:59+00:00
Accession:  0001854270-24-000094
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Senti Biosciences effectuates 1-for-10 reverse stock split effective July 17, 2024
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-10 ratio approved by Board on July 10, 2024.
- Effective 5:00 p.m. ET on July 17, 2024; trading on split-adjusted basis begins July 18 under symbol SNTI.
- No fractional shares issued; cash payment in lieu at July 17 closing price.
- Authorized shares and par value remain unchanged; new CUSIP is 81726A209.
- Reverse split intended to maintain Nasdaq listing compliance; proportional adjustments to equity awards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000185427024000094/0001854270-24-000094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000185427024000094/snti-20240717.htm
  HTML page:      https://secwatch.observer/filing/0001854270-24-000094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer